Fig. 7From: Bleeding events associated with a low dose (110 mg) versus a high dose (150 mg) of dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysisOther adverse outcomes associated with 110 mg versus 150 mg dabigatranBack to article page